Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Dexmedetomidine for Prevention of Postpartum Depression in Women Receiving Combined Spinal-Epidural Labor Analgesia: A Randomized Controlled Trial

NCT07501728 is registered in ClinicalTrials.gov with Chengdu Jinjiang Maternity and Child Health Hospital as lead sponsor.

NCT NCT07501728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07501728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Dexmedetomidine for Prevention of Postpartum Depression in Women Receiving Combined Spinal-Epidural Labor Analgesia: A Randomized Controlled Trial
Lead sponsor
Chengdu Jinjiang Maternity and Child Health Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
April 1, 2027
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum depression (ppd)